Biodexa Gross Profit from 2010 to 2024

BDRX Stock

5.62 0.69 14.00%

Biodexa Pharmaceticals Gross Profit yearly trend continues to be fairly stable with very little volatility. Gross Profit will likely drop to about -3.9 M in 2024. Gross Profit is the profit Biodexa Pharmaceticals makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. View All Fundamentals

Gross Profit

First Reported

2013-03-31

Previous Quarter

-1.1 M

Current Value

-1.1 M

Quarterly Volatility

1.9 M

Yuan Drop

Covid

Check Biodexa Pharmaceticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Biodexa Pharmaceticals' main balance sheet or income statement drivers, such as Depreciation And Amortization of 268.9 K, Selling General Administrative of 3.9 M or Other Operating Expenses of 11.7 M, as well as many indicators such as Price To Sales Ratio of 4.15, Dividend Yield of 0.0 or PTB Ratio of 0.34. Biodexa financial statements analysis is a perfect complement when working with Biodexa Pharmaceticals Valuation or Volatility modules.

Check out the analysis of Biodexa Pharmaceticals Correlation against competitors.

For more information on how to buy Biodexa Stock please use our How to Invest in Biodexa Pharmaceticals guide.

Latest Biodexa Pharmaceticals' Gross Profit Growth Pattern

Below is the plot of the Gross Profit of Biodexa Pharmaceticals over the last few years. Gross profit is a required income statement account that reflects total revenue of Biodexa Pharmaceticals minus its cost of goods sold. It is profit before Biodexa Pharmaceticals operating expenses, interest payments and taxes. Gross profit is also known as gross margin. It is the profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. Biodexa Pharmaceticals' Gross Profit historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Biodexa Pharmaceticals' overall financial position and show how it may be relating to other accounts over time.

View

Last Reported (4.41 M)

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Gross Profit

Timeline

Biodexa Gross Profit Regression Statistics

	Arithmetic Mean	(3,203,753)
	Coefficient Of Variation	(101.03)
	Mean Deviation	2,836,336
	Median	(3,870,300)
	Standard Deviation	3,236,683
	Sample Variance	10.5T
	Range	8.7M
	R-Value	(0.62)
	Mean Square Error	6.9T
	R-Squared	0.39
	Significance	0.01
	Slope	(451,479)
	Total Sum of Squares	146.7T

Biodexa Gross Profit History

	2024	-3.9 M
	2023	-3.7 M
	2022	-4.4 M
	2021	-4.1 M
	2020	-5.7 M
	2019	-7.2 M
	2018	-7.4 M

Other Fundumenentals of Biodexa Pharmaceticals

Gross Profit Margin

Biodexa Pharmaceticals Gross Profit component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Total Liab	Total Current Assets	Intangible Assets	Net Receivables	Short Term Debt	Common Stock	Net Tangible Assets	Net Invested Capital	Short Long Term Debt	Capital Stock	Net Working Capital	Property Plant Equipment	Current Deferred Revenue
Total Assets		0.98	-0.73	0.1	0.67	0.71	0.89	0.94	0.66	-0.38	-0.25	-0.29	0.37	0.34	-0.25	0.23	0.36	-0.17
Total Stockholder Equity	0.98		-0.8	0.09	0.62	0.59	0.92	0.9	0.59	-0.43	-0.3	-0.27	0.35	0.33	-0.3	0.29	0.33	-0.25
Net Debt	-0.73	-0.8		-0.04	-0.29	-0.2	-0.94	-0.55	-0.24	0.4	0.14	0.08	-0.09	-0.08	0.14	-0.14	-0.05	0.06
Retained Earnings	0.1	0.09	-0.04		0.1	0.33	0.02	0.18	0.0	0.83	-0.69	-0.69	0.85	0.83	-0.68	0.63	0.82	-0.61
Accounts Payable	0.67	0.62	-0.29	0.1		0.73	0.52	0.64	0.42	-0.12	-0.35	-0.35	0.46	0.44	-0.35	0.33	0.45	-0.31
Total Liab	0.71	0.59	-0.2	0.33	0.73		0.4	0.79	0.68	0.06	-0.31	-0.38	0.53	0.49	-0.3	0.25	0.53	-0.19
Total Current Assets	0.89	0.92	-0.94	0.02	0.52	0.4		0.71	0.45	-0.45	-0.2	-0.18	0.21	0.18	-0.2	0.2	0.17	-0.12
Intangible Assets	0.94	0.9	-0.55	0.18	0.64	0.79	0.71		0.59	-0.3	-0.29	-0.32	0.44	0.42	-0.28	0.25	0.44	-0.22
Net Receivables	0.66	0.59	-0.24	0.0	0.42	0.68	0.45	0.59		-0.24	0.0	-0.05	0.16	0.14	0.0	-0.03	0.19	0.03
Short Term Debt	-0.38	-0.43	0.4	0.83	-0.12	0.06	-0.45	-0.3	-0.24		-0.43	-0.48	0.59	0.57	-0.42	0.37	0.58	-0.35
Common Stock	-0.25	-0.3	0.14	-0.69	-0.35	-0.31	-0.2	-0.29	0.0	-0.43		0.78	-0.8	-0.84	1.0	-0.96	-0.65	0.87
Net Tangible Assets	-0.29	-0.27	0.08	-0.69	-0.35	-0.38	-0.18	-0.32	-0.05	-0.48	0.78		-0.77	-0.89	0.78	-0.63	-0.61	0.69
Net Invested Capital	0.37	0.35	-0.09	0.85	0.46	0.53	0.21	0.44	0.16	0.59	-0.8	-0.77		0.94	-0.79	0.75	0.96	-0.64
Short Long Term Debt	0.34	0.33	-0.08	0.83	0.44	0.49	0.18	0.42	0.14	0.57	-0.84	-0.89	0.94		-0.83	0.71	0.85	-0.73
Capital Stock	-0.25	-0.3	0.14	-0.68	-0.35	-0.3	-0.2	-0.28	0.0	-0.42	1.0	0.78	-0.79	-0.83		-0.96	-0.64	0.87
Net Working Capital	0.23	0.29	-0.14	0.63	0.33	0.25	0.2	0.25	-0.03	0.37	-0.96	-0.63	0.75	0.71	-0.96		0.64	-0.84
Property Plant Equipment	0.36	0.33	-0.05	0.82	0.45	0.53	0.17	0.44	0.19	0.58	-0.65	-0.61	0.96	0.85	-0.64	0.64		-0.57
Current Deferred Revenue	-0.17	-0.25	0.06	-0.61	-0.31	-0.19	-0.12	-0.22	0.03	-0.35	0.87	0.69	-0.64	-0.73	0.87	-0.84	-0.57

Click cells to compare fundamentals

About Biodexa Pharmaceticals Financial Statements

Biodexa Pharmaceticals investors use historical fundamental indicators, such as Biodexa Pharmaceticals' Gross Profit, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Biodexa Pharmaceticals. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Gross Profit	-3.7 M	-3.9 M
Gross Profit Margin	(9.67)	(10.16)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C

Additional Tools for Biodexa Stock Analysis

When running Biodexa Pharmaceticals' price analysis, check to measure Biodexa Pharmaceticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biodexa Pharmaceticals is operating at the current time. Most of Biodexa Pharmaceticals' value examination focuses on studying past and present price action to predict the probability of Biodexa Pharmaceticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biodexa Pharmaceticals' price. Additionally, you may evaluate how the addition of Biodexa Pharmaceticals to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC